Chemoinformaics analysis of 4-Methylpyrrolidine-2-carboxylic acid
Molecular Weight | 129.159 | nRot | 1 |
Heavy Atom Molecular Weight | 118.071 | nRig | 6 |
Exact Molecular Weight | 129.079 | nRing | 1 |
Solubility: LogS | -0.53 | nHRing | 1 |
Solubility: LogP | -1.916 | No. of Aliphatic Rings | 1 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 6 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 20.0587 |
nHD | 2 | BPOL | 12.4733 |
QED | 0.526 |
Synth | 3.369 |
Natural Product Likeliness | 1.452 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.002 |
HIA | 0.025 |
CACO-2 | -5.565 |
MDCK | 0.0000379 |
BBB | 0.586 |
PPB | 0.0501621 |
VDSS | 0.582 |
FU | 0.893858 |
CYP1A2-inh | 0.015 |
CYP1A2-sub | 0.089 |
CYP2c19-inh | 0.037 |
CYP2c19-sub | 0.166 |
CYP2c9-inh | 0.007 |
CYP2c9-sub | 0.507 |
CYP2d6-inh | 0.012 |
CYP2d6-sub | 0.383 |
CYP3a4-inh | 0.007 |
CYP3a4-sub | 0.046 |
CL | 7.375 |
T12 | 0.737 |
hERG | 0.013 |
Ames | 0.006 |
ROA | 0.798 |
SkinSen | 0.304 |
Carcinogencity | 0.346 |
EI | 0.483 |
Respiratory | 0.693 |
NR-Aromatase | 0.003 |
Antiviral | No |
Prediction | 0.931206 |